These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The risks of extending the controversial use of tocolytic magnesium sulfate for the purpose of neuroprotection in preterm labor. Mittendorf R; Roizen NJ; Pryde PG J Perinatol; 2004 Jul; 24(7):465-6. PubMed ID: 15224123 [No Abstract] [Full Text] [Related]
8. Magnesium neuroprotection is limited in humans with acute brain injury. McKee JA; Brewer RP; Macy GE; Borel CO; Reynolds JD; Warner DS Neurocrit Care; 2005; 2(3):342-51. PubMed ID: 16159086 [TBL] [Abstract][Full Text] [Related]
9. [The intervention treatment of neuroprotection for ischemic stroke]. Wang YL; Liang H; Song SL Sheng Li Ke Xue Jin Zhan; 2012 Aug; 43(4):279-82. PubMed ID: 23189623 [No Abstract] [Full Text] [Related]
10. Magnesium sulfate for brain protection during temporary cerebral artery occlusion. Chan MT; Boet R; Ng SC; Poon WS; Gin T Acta Neurochir Suppl; 2005; 95():107-11. PubMed ID: 16463831 [TBL] [Abstract][Full Text] [Related]
11. Pilot study to determine the hemodynamic safety and feasibility of magnesium sulfate infusion in children with severe traumatic brain injury. Natale JE; Guerguerian AM; Joseph JG; McCarter R; Shao C; Slomine B; Christensen J; Johnston MV; Shaffner DH Pediatr Crit Care Med; 2007 Jan; 8(1):1-9. PubMed ID: 17251875 [TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke. Muir KW; Lees KR Ann N Y Acad Sci; 1995 Sep; 765():315-6. PubMed ID: 7486627 [No Abstract] [Full Text] [Related]
14. The effect of hypermagnesemic treatment on cerebrospinal fluid magnesium level in patients with aneurysmal subarachnoid hemorrhage. Wong GK; Lam CW; Chan MT; Gin T; Poon WS Magnes Res; 2009 Jun; 22(2):60-5. PubMed ID: 19658274 [TBL] [Abstract][Full Text] [Related]
15. Magnesium sulphate in the management of patients with aneurysmal subarachnoid haemorrhage: a meta-analysis of prospective controlled trials. Ma L; Liu WG; Zhang JM; Chen G; Fan J; Sheng HS Brain Inj; 2010; 24(5):730-5. PubMed ID: 20334471 [TBL] [Abstract][Full Text] [Related]
16. Intravenous magnesium in subarachnoid hemorrhage. Abdo WF; Hoedemaekers CW; van der Hoeven JG Crit Care; 2011; 15(3):427; author reply 427. PubMed ID: 21631908 [No Abstract] [Full Text] [Related]
17. Prosurvival NMDA 2A receptor signaling mediates postconditioning neuroprotection in the hippocampus. Zhang X; Zhang Q; Tu J; Zhu Y; Yang F; Liu B; Brann D; Wang R Hippocampus; 2015 Mar; 25(3):286-96. PubMed ID: 25271147 [TBL] [Abstract][Full Text] [Related]
18. Novel neuroprotective effect of cisternal and intra-cerebral magnesium sulfate solution infusion on delayed cerebral death in rat hippocampal neurons after transient global ischemia. Mori K; Yamamoto T; Nakao Y; Miyazaki M; Iwata J; Tamura M; Shiroishi T Brain Res; 2012 Oct; 1480():72-80. PubMed ID: 22842083 [TBL] [Abstract][Full Text] [Related]